September 28, 2018/US SEC The Securities and Exchange Commission today charged a Florida-based microcap issuer, its CEO, and one of its consultants with making material misstatements to retail investors, among other charges. According to the SEC’s complaint, Nutra Pharma Corp., a microcap issuer that purports to make pain relief drugs […]
Frauds & Scandals
SEC Charges Salix Pharmaceuticals and Former CFO With Lying About Distribution Channel
September 28, 2018/US SEC The Securities and Exchange Commission today charged Salix Pharmaceuticals Ltd. and its former CFO with repeatedly misleading analysts and investors about the company’s future prospects. The former CFO, Adam Derbyshire, will pay more than $1 million to settle the charges. According to the SEC’s complaint, Salix […]
SEC Charges Australia-Based Investment Adviser with Fraud
September 28, 2018/US SEC The Securities and Exchange Commission filed charges against an Australia-based investment adviser Goldsky Asset Management, LLC and its owner, Kenneth Grace, for making false and misleading statements about its business in filings with the Commission and on its website. According to the SEC’s complaint, Goldsky’s Forms […]
